Literature DB >> 16737724

Exposure to a lithium-paired context elicits gaping in rats: A model of anticipatory nausea.

Cheryl L Limebeer1, Geoffrey Hall, Linda A Parker.   

Abstract

Chemotherapy patients report anticipatory nausea and vomiting upon re-exposure to the cues previously associated with the treatment. Although rats do not vomit, they display a distinctive gaping reaction when exposed to a toxin-paired flavored solution. Here we report that rats also display gaping reactions during exposure to a context previously paired with the illness-inducing effects of lithium chloride (Experiment 1). This gaping reaction is suppressed by pretreatment with the antiemetic agent, Delta 9-tetrahydrocannabinol, but not ondansetron (Experiment 2). The finding that gaping is elicited by an illness-paired context confirms the proposal that an illness-paired context can evoke a conditioned state of nausea and supports the case of context-aversion as a rat model for anticipatory nausea.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737724     DOI: 10.1016/j.physbeh.2006.04.014

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  30 in total

1.  Aversive, appetitive and flavour avoidance responses in the presence of contextual cues.

Authors:  Adam R Brown; Alexander M Penney; Darlene M Skinner; Gerard M Martin
Journal:  Learn Behav       Date:  2011-05       Impact factor: 1.986

Review 2.  Regulation of nausea and vomiting by cannabinoids.

Authors:  Linda A Parker; Erin M Rock; Cheryl L Limebeer
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

3.  The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat.

Authors:  Erin M Rock; Cheryl L Limebeer; Raphael Mechoulam; Daniele Piomelli; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2007-11-09       Impact factor: 4.530

4.  Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2015-09-18       Impact factor: 4.530

5.  Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.

Authors:  Cheryl L Limebeer; Rehab A Abdullah; Erin M Rock; Elizabeth Imhof; Kai Wang; Aron H Lichtman; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2013-09-17       Impact factor: 4.530

Review 6.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

7.  Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats.

Authors:  E M Rock; L A Parker
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

8.  Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex interferes with anticipatory nausea in a rat model.

Authors:  Cheryl L Limebeer; Erin M Rock; Nirushan Puvanenthirarajah; Micah J Niphakis; Benjamin F Cravatt; Linda A Parker
Journal:  Behav Neurosci       Date:  2016-04       Impact factor: 1.912

Review 9.  What is nausea? A historical analysis of changing views.

Authors:  Carey D Balaban; Bill J Yates
Journal:  Auton Neurosci       Date:  2016-07-16       Impact factor: 3.145

10.  Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus.

Authors:  Linda A Parker; Micah J Niphakis; Rachel Downey; Cheryl L Limebeer; Erin M Rock; Martin A Sticht; Heather Morris; Rehab A Abdullah; Aron H Lichtman; Benjamin F Cravatt
Journal:  Psychopharmacology (Berl)       Date:  2014-08-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.